naion glp 1 Breaking Med Anterior ischemic optic neuropathy in
Description
Watts, A

Semaglutide, a GLP-1 analog, was approved in 2020 as a therapy for improving glycemic control in Type 2 diabetes patients
GLP-1 drugs have become widely-known for suppressing a users appetite

For example, some programs have demonstrated that members who dont take GLP-1s but do engage in intensive lifestyle modification still achieve significant weight loss (around 9% loss after one year, according to data from one of our partners)

GLP-1 meds may reduce inflammation, improve metabolism, and help people feel less tired and achy

Comparing GLP-1 options for HRT users Not all GLP-1 medications interact with HRT in exactly the same way
